Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis

Journal of Infection and Chemotherapy

Volumn 11, Issue 5, 2005, Pages 234-238

  Yaegashi, Yasunori ^a   Shirakawa, Kamon ^b   Sato, Nobuhiro ^a   Suzuki, Yasushi ^a   Kojika, Masahiro ^a   Imai, Satoko ^a   Takahashi, Gaku ^a   Miyata, Michiko ^a   Furusako, Shoji ^b   Endo, Shigeatsu ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

CD14; Diagnosis; EIA; Sepsis; SIRS

Indexed keywords

GLYCOPROTEIN; LIPOPOLYSACCHARIDE; MOLECULAR MARKER; PROCALCITONIN; SOLUBLE CD14 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME IMMUNOASSAY; HUMAN; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; ROC CURVE; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 27644486997     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-005-0400-4     Document Type: Article

References (18)

1. E Ferrero SM Goyert 1988 Nucleotide sequence of the gene encoding the monocyte differentiation antigen, CD14 Nucleic Acids Res 16 4173
2. SD Wright RA Ramos PS Tobias RJ Ulevitch JC Mathison 1990 CD14, a receptor for complex of lipopolysaccharide (LPS) and LPS binding protein Science 249 1431 33
3. DT Golenbock RR Bach H Lichenstein TS Juan A Tadavarthy CF Moldow 1995 Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells J Lab Clin Med 125 662 71
4. U Grunwald C Krüger J Westermann A Lukowsky M Ehlers C Shütt 1992 An enzyme-linked immunosorbent assay for the quantification of solubilized CD14 in biological fluids J Immunol Methods 155 225 32
5. R Landmann W Zimmerli S Sansano S Link A Hahn MP Glauser 1995 Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock J Infect Dis 171 639 44
6. S Endo K Inada T Kasai T Takakuwa H Nakae M Kikuchi 1994 Soluble CD14 (sCD14) levels in patients with multiple organ failure (MOF) Res Commun Chem Pathol Pharmacol 84 17 25
7. E Lien P Aukrust A Sundan F Muller SS Froland T Espevik 1998 Elevated levels of serum-soluble CD14 in human immunodefiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events Blood 92 2084 92
8. TR Martin GD Rubenfeld JT Ruzinski RB Goodman KP Steinberg DJ Leturcq 1997 Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome Am J Respir Crit Care Med 155 937 44
9. WA Nockher R Wigarnd W Schoeppe JE Scherberich 1994 Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus Clin Exp Immunol 96 15 9
10. JW Lee MJ Paape X Zhao 2003 Recombinant bovine CD14 reduces severity of experimental Escherichia coli mastitis in mice Vet Res 34 307 16
11. R Landmann AM Reber S Sansano W Zimmerli 1996 Function of soluble CD14 in serum from patients with septic shock J Infect Dis 173 661 8
12. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference 1992 Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 20 864 74
13. M Assicot D Gendrel H Carsin J Raymond J Guilbaud C Bohuon 1993 High serum procalcitonin concentrations in patients with sepsis and infection Lancet 341 515 18
14. P Bufler G Stieger M Schuchmann S Hess C Krüger F Stelter 1995 Soluble lipopolysaccharide receptor (CD14) released via two different mechanisms from human monocytes and CD14 transfectants Eur J Immunol 25 604 10
15. V Bazil JL Strominger 1991 Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes J Immunol 147 1567 74
16. RP Dellinger JN Carlet H Masur H Gerlach T Calandra J Cohen 2004 Surviving sepsis campaign guidelines for management of severe sepsis and septic shock Intensive Care Med 30 536 55
17. S Oliver H Hartmut M Michael K Andreas B Wilfried K Jörg 2000 Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6 Crit Care Med 28 2793 98
18. RG Holzheimer P Capel JM Cavaillon M Cainzos P Frileux W Haupt 2000 Immunological surrogate parameters in a prognostic model for multi-organ failure and death Eur J Med Res 5 283 94